Access Resources
7326 - 7350 of 7540 Results
Title
Year
- Evaluation of the Braak staging scheme for Parkinson's disease: Introduction to a panel presentation2010RESTRICTEDTitle: Evaluation of the Braak staging scheme for Parkinson's disease: Introduction to a panel presentationJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: S1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.22783Best OA location URL: https://europepmc.org/articles/pmc2929458?pdf=renderCitation Count: 14
- Increased Expression of α-Synuclein Reduces Neurotransmitter Release by Inhibiting Synaptic Vesicle Reclustering after Endocytosis2010RESTRICTEDTitle: Increased Expression of α-Synuclein Reduces Neurotransmitter Release by Inhibiting Synaptic Vesicle Reclustering after EndocytosisJournal Name: NeuronPublisher: Elsevier BVVol: 65Issue #: 1Start Page: 66End Page: 79Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.neuron.2009.12.023Best OA location URL: http://www.cell.com/article/S0896627309010411/pdfCitation Count: 889
-
RESTRICTEDTitle: LRRK2 and the Stress Response: Interaction with MKKs and JNK-Interacting ProteinsJournal Name: Neurodegenerative DiseasesPublisher: S. Karger AGVol: 7Issue #: 1-3Start Page: 68End Page: 75Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1159/000285509Best OA location URL: https://karger.com/ndd/article-pdf/7/1-3/68/3138541/000285509.pdfCitation Count: 53
-
RESTRICTEDTitle: Mitochondrial therapies for Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: S1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.22781Best OA location URL: https://europepmc.org/articles/pmc5797696?pdf=renderCitation Count: 48
- New developments in depression, anxiety, compulsiveness, and hallucinations in Parkinson's disease2010RESTRICTEDTitle: New developments in depression, anxiety, compulsiveness, and hallucinations in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: S1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.22636Citation Count: 40
- Role of serotonin neurons in the induction of levodopa‐ and graft‐induced dyskinesias in Parkinson's disease2010RESTRICTEDTitle: Role of serotonin neurons in the induction of levodopa‐ and graft‐induced dyskinesias in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: S1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.22792Citation Count: 69
-
RESTRICTEDTitle: The antipsychotic potential of muscarinic allosteric modulationJournal Name: Drug News & PerspectivesPublisher: PorticoVol: 23Issue #: 4Start Page: 229End Page: 229Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1358/dnp.2010.23.4.1416977Best OA location URL: https://europepmc.org/articles/pmc4780339?pdf=renderCitation Count: 55
-
RESTRICTEDTitle: Therapeutic directions for Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: S1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.22790Best OA location URL: https://europepmc.org/articles/pmc3110693?pdf=renderCitation Count: 5
- α-Synuclein Gene May Interact with Environmental Factors in Increasing Risk of Parkinson’s Disease2010RESTRICTEDTitle: α-Synuclein Gene May Interact with Environmental Factors in Increasing Risk of Parkinson’s DiseaseJournal Name: NeuroepidemiologyPublisher: S. Karger AGVol: 35Issue #: 3Start Page: 191End Page: 195Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1159/000315157Best OA location URL: https://europepmc.org/articles/pmc2945263?pdf=renderCitation Count: 60
- Are there differences in cerebral white matter lesion burdens between Parkinson’s disease patients with or without dementia?2009RESTRICTEDTitle: Are there differences in cerebral white matter lesion burdens between Parkinson’s disease patients with or without dementia?Journal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 119Issue #: 1Start Page: 147End Page: 149Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00401-009-0620-2Best OA location URL: https://europepmc.org/articles/pmc2928051?pdf=renderCitation Count: 44
- Neuromelanin Activates Microglia and Induces Degeneration of Dopaminergic Neurons: Implications for Progression of Parkinson’s Disease2009RESTRICTEDTitle: Neuromelanin Activates Microglia and Induces Degeneration of Dopaminergic Neurons: Implications for Progression of Parkinson’s DiseaseJournal Name: Neurotoxicity ResearchPublisher: Springer Science and Business Media LLCVol: 19Issue #: 1Start Page: 63End Page: 72Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s12640-009-9140-zBest OA location URL: https://europepmc.org/articles/pmc3603276?pdf=renderCitation Count: 201
-
RESTRICTEDTitle: Glutamate Receptors as Therapeutic Targets for Parkinsons DiseaseJournal Name: CNS & Neurological Disorders - Drug TargetsPublisher: Bentham Science Publishers Ltd.Vol: 8Issue #: 6Start Page: 475End Page: 491Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2174/187152709789824606Best OA location URL: https://europepmc.org/articles/pmc3005251?pdf=renderCitation Count: 220
- Targeting of gp78 for ubiquitin-mediated proteasomal degradation by Hrd1: Cross-talk between E3s in the endoplasmic reticulum2009RESTRICTEDTitle: Targeting of gp78 for ubiquitin-mediated proteasomal degradation by Hrd1: Cross-talk between E3s in the endoplasmic reticulumJournal Name: Biochemical and Biophysical Research CommunicationsPublisher: Elsevier BVVol: 390Issue #: 3Start Page: 758End Page: 762Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.bbrc.2009.10.045Best OA location URL: https://europepmc.org/articles/pmc3014991?pdf=renderCitation Count: 53
- Dopamine D3 receptor selective ligands with varying intrinsic efficacies at adenylyl cyclase inhibition and mitogenic signaling pathways2009RESTRICTEDTitle: Dopamine D3 receptor selective ligands with varying intrinsic efficacies at adenylyl cyclase inhibition and mitogenic signaling pathwaysJournal Name: SynapsePublisher: WileyVol: 64Issue #: 3Start Page: 251End Page: 266Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/syn.20725Best OA location URL: https://europepmc.org/articles/pmc3821045?pdf=renderCitation Count: 21
-
RESTRICTEDTitle: Safety and tolerability of putaminal AADC gene therapy for Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 73Issue #: 20Start Page: 1662End Page: 1669Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e3181c29356Best OA location URL: https://europepmc.org/articles/pmc2839805?pdf=renderCitation Count: 363
- Vesicular monoamine transporter 2 and dopamine transporter are molecular targets of Pitx3 in the ventral midbrain dopamine neurons2009RESTRICTEDTitle: Vesicular monoamine transporter 2 and dopamine transporter are molecular targets of Pitx3 in the ventral midbrain dopamine neuronsJournal Name: Journal of NeurochemistryPublisher: WileyVol: 111Issue #: 5Start Page: 1202End Page: 1212Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/j.1471-4159.2009.06404.xBest OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1471-4159.2009.06404.xCitation Count: 52
-
RESTRICTEDTitle: Microglial responses to dopamine in a cell culture model of Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 30Issue #: 11Start Page: 1805End Page: 1817Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2008.01.001Best OA location URL: https://europepmc.org/articles/pmc2762863?pdf=renderCitation Count: 91
-
RESTRICTEDTitle: Proteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer’s diseaseJournal Name: BiomarkersPublisher: Informa UK LimitedVol: 14Issue #: 7Start Page: 493End Page: 501Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3109/13547500903108423Best OA location URL: https://europepmc.org/articles/pmc2824250?pdf=renderCitation Count: 105
-
RESTRICTEDTitle: LRRK2 in Parkinson’s disease: function in cells and neurodegenerationJournal Name: The FEBS JournalPublisher: WileyVol: 276Issue #: 22Start Page: 6436End Page: 6444Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/j.1742-4658.2009.07342.xBest OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1742-4658.2009.07342.xCitation Count: 32
-
RESTRICTEDTitle: LRRK2 in Parkinson’s disease: in vivo models and approaches for understanding pathogenic rolesJournal Name: FEBS JournalPublisher: WileyVol: 276Issue #: 22Start Page: 6445End Page: 6454Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/j.1742-4658.2009.07343.xBest OA location URL: https://europepmc.org/articles/pmc2827245?pdf=renderCitation Count: 21
-
RESTRICTEDTitle: Substrate specificity and inhibitors of LRRK2, a protein kinase mutated in Parkinson's diseaseJournal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 424Issue #: 1Start Page: 47End Page: 60Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1042/bj20091035Best OA location URL: https://hal.archives-ouvertes.fr/hal-00479223/file/PEER_stage2_10.1042%252FBJ20091035.pdfCitation Count: 186
- Compacted DNA Nanoparticle Gene Transfer of GDNF to the Rat Striatum Enhances the Survival of Grafted Fetal Dopamine Neurons2009RESTRICTEDTitle: Compacted DNA Nanoparticle Gene Transfer of GDNF to the Rat Striatum Enhances the Survival of Grafted Fetal Dopamine NeuronsJournal Name: Cell TransplantationPublisher: SAGE PublicationsVol: 18Issue #: 10-11Start Page: 1183End Page: 1196Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3727/096368909x12483162196881Best OA location URL: https://journals.sagepub.com/doi/pdf/10.3727/096368909X12483162196881Citation Count: 68
-
RESTRICTEDTitle: Genetic interaction between Lrp6 and Wnt5a during mouse developmentJournal Name: Developmental DynamicsPublisher: WileyVol: 239Issue #: 1Start Page: 237End Page: 245Publication Date:Open Access(OA) Status: RESTRICTEDLicense: public-domainDOI - Digital Object Identifier: 10.1002/dvdy.22101Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/dvdy.22101Citation Count: 19
-
RESTRICTEDTitle: Genomewide association study for onset age in Parkinson diseaseJournal Name: BMC Medical GeneticsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/1471-2350-10-98Best OA location URL: https://bmcmedgenet.biomedcentral.com/counter/pdf/10.1186/1471-2350-10-98Citation Count: 106
-
RESTRICTEDTitle: Is the N-Back Task a Valid Neuropsychological Measure for Assessing Working Memory?Journal Name: Archives of Clinical NeuropsychologyPublisher: Oxford University Press (OUP)Vol: 24Issue #: 7Start Page: 711End Page: 717Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1093/arclin/acp063Best OA location URL: https://academic.oup.com/acn/article-pdf/24/7/711/11189/acp063.pdfCitation Count: 169